24-h Glycaemic profiles in peritoneal dialysis patients and non-dialysis controls with advanced kidney disease

1. Mahmoodi, BK, Matsushita, K, Woodward, M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; 380: 1649–1661.
Google Scholar | Crossref | Medline2. Fox, CS, Matsushita, K, Woodward, M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662–1673.
Google Scholar | Crossref | Medline3. Heimburger, O, Waniewski, J, Werynski, A, et al. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320–1332.
Google Scholar | Crossref | Medline4. Wang, IK, Lin, CL, Chen, HC, et al. Risk of new-onset diabetes in end-stage renal disease patients undergoing dialysis: analysis from registry data of Taiwan. Nephrol Dial Transplant 2018; 33: 670–675.
Google Scholar | Crossref | Medline5. Chou, CY, Liang, CC, Kuo, HL, et al. Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLoS ONE 2014; 9: e87891.
Google Scholar | Crossref | Medline6. Tien, K-J, Lin, Z-Z, Chio, C-C, et al. Epidemiology and mortality of new-onset diabetes after dialysis. Taiwan national cohort study. Diabetes Care 2013; 36: 3027–3032.
Google Scholar | Crossref | Medline7. Lambie, M, Chess, J, Do, JY, et al. Peritoneal dialysate glucose load and systemic glucose metabolism in non-diabetics: results from the GLOBAL fluid cohort study. PLoS ONE 2016; 11: e0155564.
Google Scholar | Crossref | Medline8. Dong, J, Yang, ZK, Chen, Y. Older age, higher body mass index and inflammation increase the risk for new-onset diabetes and impaired glucose tolerance in patients on peritoneal dialysis. Perit Dial Int 2016; 36: 277–283.
Google Scholar | SAGE Journals9. Bernardo, AP, Oliveira, JC, Santos, O, et al. Insulin resistance in nondiabetic peritoneal dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption. Clin J Am Soc Nephrol CJASN 2015; 10: 2205–2212.
Google Scholar | Crossref | Medline10. Williams, ME, Lacson, E, Wang, W, et al. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol CJASN 2010; 5: 1595–1601.
Google Scholar | Crossref | Medline11. Inaba, M, Okuno, S, Kumeda, Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol JASN 2007; 18: 896–903.
Google Scholar | Crossref | Medline12. Ng, JM, Cooke, M, Bhandari, S, et al. The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care 2010; 33: 2310–2313.
Google Scholar | Crossref | Medline13. Rodbard, D . Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther 2016; 18 Suppl 2: S3–S13.
Google Scholar | Medline14. Schwing, WD, Erhard, P, Newman, LN, et al. Assessing 24-hour blood glucose patterns in diabetic patients treated by peritoneal dialysis. Adv Perit Dial Conf Perit Dial 2004; 20: 213–216.
Google Scholar | Medline15. Okada, E, Oishi, D, Sakurada, T, et al. A comparison study of glucose fluctuation during automated peritoneal dialysis and continuous ambulatory peritoneal dialysis. Adv Perit Dial 2015; 31: 34–37.
Google Scholar | Medline16. Marshall, J, Jennings, P, Scott, A, et al. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64: 1480–1486.
Google Scholar | Crossref | Medline17. Pisprasert, V, Ingram, KH, Lopez-Davila, MF, et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013; 36: 845–853.
Google Scholar | Crossref | Medline18. Haak, T, Hanaire, H, Ajjan, R, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017; 8: 55–73.
Google Scholar | Crossref | Medline19. Flowers, K, Kirk, A, Turner, L, et al. Diabetes and real-world investigation of glucose instability, variability and exposure in haemodialysis patients (DRIVE-HD) – a technology validation. https://britishrenal.org/wp-content/uploads/2021/02/P346.pdf (2021, accessed 01 July 2021).
Google Scholar20. Schleis, TG . Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007; 27: 1313–1321.
Google Scholar | Crossref | Medline21. Galindo, RJ, Beck, RW, Scioscia, MF, et al. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev 2020; 41: 756–774.
Google Scholar | Crossref22. Hill, NR, Oliver, NS, Choudhary, P, et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011; 13: 921–928.
Google Scholar | Crossref | Medline23. Battelino, T, Danne, T, Bergenstal, RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42: 1593–1603.
Google Scholar | Crossref | Medline24. Mori, T, Chida, M, Oba, I, et al. Diurnal variations of blood glucose by continuous blood glucose monitoring in peritoneal dialysis patients with diabetes. Adv Perit Dial 2014; 30: 54–59.
Google Scholar | Medline25. Van Cauter, E, Desir, D, Decoster, C, et al. Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab 1989; 69: 604–611.
Google Scholar | Crossref | Medline26. Van Cauter, E, Polonsky, KS, Scheen, AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997; 18: 716–738.
Google Scholar | Crossref | Medline27. Arble, DM, Bass, J, Laposky, AD, et al. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring) 2009; 17: 2100–2102.
Google Scholar | Crossref | Medline28. Gill, S, Panda, S. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Cell Metab 2015; 22: 789–798.
Google Scholar | Crossref | Medline29. Sutton, EF, Beyl, R, Early, KS, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab 2018; 27: 1212–1221 e1213.
Google Scholar | Crossref | Medline30. Shai, I, Jiang, R, Manson, JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 2006; 29: 1585–1590.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif